IMNM - CIK 0001472012
The table below shows Immunome Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $582.69M | $272.64M | $143.88M | $257.61M | $155.57M | $165.33M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $594.31M |
| $279.92M |
| $277.43M |
| $323.13M |
| $244.04M |
| $284.28M |
| Property, plant & equipment | $17.08M | $11.56M | $11.03M | $10.95M | $7.17M | $6.10M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $619.79M | $299.38M | $296.29M | $342.69M | $256.90M | $296.21M |
| Accounts payable | $5.53M | $6.15M | $4.66M | $9.13M | $3.52M | $7.05M |
| Total current liabilities | $27.41M | $31.45M | $22.88M | $30.80M | $39.53M | $39.90M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $31.11M | $35.46M | $27.02M | $35.57M | $41.99M | $42.38M |
| Retained earnings | -$782.00M | -$658.26M | -$600.81M | -$557.41M | -$435.52M | -$388.42M |
| Total equity | $588.69M | $263.92M | $269.27M | $307.13M | $214.91M | $253.84M |